Fachliteratur Gastroenterologie: Neoplasien der Gallenwege

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Gallenwege » Neoplasie

04. Juli 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Fachliteratursuche

Gallenwege

Cholezystitis - Cholelithiasis

Schrift:

Seite 1 von 813


	Artikel 1 - 20 / 16241

	Single cell RNA sequencing to identify an Immunogenic cell death related prognostic signature in intrahepatic cholangiocarcinoma. Sci Rep Sha B, Tong F, Shu Q, Wu M, Zhao L, Zhang Y. PMID: 40604056 [PubMed - indexed for MEDLINE]
	Updated Japanese multicenter registry study evaluates the efficacy and safety of proton beam therapy for treating extrahepatic cholangiocarcinoma. Sci Rep Yamazaki H, Shibuya K, Kimoto T, Suzuki M, Murakami M, Terashima K, Okimoto T, Iizumi T, Sakurai H, Wakatsuki M, Ogino T, Arimura T, Takagi M, Araya M, Waki T, Matsumoto S, Ogino H, Katoh N, Hashimoto T, Hojo H, Fukumitsu N, Fukumoto T, Ohtsuka M. PMID: 40603425 [PubMed - indexed for MEDLINE]
	Prognostic impact of neutrophil-to-lymphocyte ratio (NLR) in patients with unresectable biliary tract cancer treated with gemcitabine, cisplatin, and durvalumab. World J Surg Oncol Mii S, Kato H, Takahara T, Kojima M, Kato Y, Morise Z, Horiguchi A, Suda K. PMID: 40598212 [PubMed - indexed for MEDLINE]
	Hepatic arterial infusion chemotherapy with Folfox 4 regimen versus cisplatin and gemcitabine for locally advanced intrahepatic cholangiocarcinoma. Sci Rep Liu L, Wang H, Sun L, Liu Y, Zhang Y, Wang X, Zheng X. PMID: 40596432 [PubMed - indexed for MEDLINE]
	Immunomics-guided biomarker discovery for human liver fluke infection and infection-associated cholangiocarcinoma. Nat Commun Sadaow L, Rodpai R, Smout MJ, Nakajima R, Boonroumkaew P, Sotillo J, Tedla BA, Luvira V, Kitkhuandee A, Paonariang K, Sukeepaisarnjaroen W, Yamasaki H, Suttiprapa S, Laha T, Sripa B, de Assis R, Jain A, Ittiprasert W, Mann VH, Wong Y, Felgner PL, Maleewong W, Brindley PJ, Loukas A, Intapan PM. PMID: 40595543 [PubMed - indexed for MEDLINE]
	Phase II study of transcatheter arterial chemoembolization (TACE) combined with apatinib for advanced perihilar cholangiocarcinoma. Sci Rep Li H, Chen P, Zhang M, Wang Z, Lian Y, Wen B, Ren J, Han X, Li B, Duan X. PMID: 40594055 [PubMed - indexed for MEDLINE]
	Sintilimab and anlotinib with gemcitabine plus cisplatin in advanced biliary tract cancer: SAGC a randomized phase 2 trial. Nat Commun Li J, Zhou S, Xu X, Zheng Q, Zhang F, Luo C, Li D, Sun X, Han Z, Wu W, Yan J, Shao Y, Zhang Y, Wu B, Wei Q, Wang X, Zhou Y, Sun W, Xu Q, Ying J. PMID: 40593475 [PubMed - indexed for MEDLINE]
	Machine learning-driven prediction of immune checkpoint inhibitor responses against cholangiocarcinoma: a bile biopsy perspective. Front Immunol Zhang D, Li X, Wang Z, Fan J, Yang Y, Han S, Sun W, Wang D, Zhou S, Liu Z, Chen S, Yang Y, Zhu Y, Lu Z. PMID: 40589739 [PubMed - indexed for MEDLINE]
	Retrospective Comparison of Initial vs. Subsequent Simultaneous Side-by-Side Stenting with Uncovered Metal Stents during Endoscopic Retrograde Cholangiopancreatography for Unresectable Malignant Hilar Biliary Obstructions. J Gastrointestin Liver Dis Takahashi K, Ohyama H, Kan M, Ouchi M, Nagashima H, Okitsu K, Ohno I, Kato N. PMID: 40580541 [PubMed - indexed for MEDLINE]
	Cholangiocarcinoma in Rhode Island: Incidence Trends and Risk Profile Over the Last Decade. R I Med J (2013) Lightfoot S, Ram S, Calvino AS. PMID: 40561241 [PubMed - indexed for MEDLINE]
	Prognostic Factors and Treatment Outcomes in Gallbladder Cancer Patients Undergoing Curative Surgery: A Multicenter Retrospective Cohort Study. Curr Oncol Xu B, Yin Y, Chang J, Li Z, Bi X, Cai J, Chen X. PMID: 40558271 [PubMed - indexed for MEDLINE]
	Therapeutic Advances in Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma: Emerging Treatments and the Role of Liver Transplantation. Curr Oncol Lopiano S, Guarrera JV, Lunsford KE. PMID: 40558236 [PubMed - indexed for MEDLINE]
	Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study. Oncologist Blanc JF, Bouattour M, Gauthier L, Deshayes E, Guillemard S, Touchefeu Y, Portales F, Borg C, Harguem L, Guimbaud R, Mineur L, Ychou M, Mazard T, Assenat E. PMID: 40542585 [PubMed - indexed for MEDLINE]
	Outcome prediction for cholangiocarcinoma prognosis: Embracing the machine learning era. World J Gastroenterol Morales-Galicia AE, Rincón-Sánchez MN, Ramírez-Mejía MM, Méndez-Sánchez N. PMID: 40538509 [PubMed - indexed for MEDLINE]
	Primary Non-Hodgkin Lymphoma of the Liver and Gallbladder Diagnosed by Laparoscopic Segment 8 Subsegmentectomy and Cholecystectomy: A Rare Case Report. J Investig Med High Impact Case Rep Nitta T, Ishii M, Taki M, Kubo R, Sada A, Takeshita A, Ishibashi T. PMID: 40538186 [PubMed - indexed for MEDLINE]
	Expression of inflammatory proteins STAT & NFÄ¸B for phenotypic diagnosis of gall bladder cancer: A pilot study. Indian J Med Res Sen A, Choudhary N, Goyal B, Gupta A, Gupta S, Mirza AA, Kumar A. PMID: 40536380 [PubMed - indexed for MEDLINE]
	Treatment with gemcitabine/cisplatin and durvalumab for advanced biliary tract cancer - real-world data from a multicenter German patient population. J Cancer Res Clin Oncol Gerhardt F, Müller C, Venerito M, Chater J, Mohr R, Egerer M, Lindig U, Schindler A, Ebel S, Fischer J, Schwarz M, Gehring S, Berg T, van Bömmel F. PMID: 40533571 [PubMed - indexed for MEDLINE]
	Integrative Machine Learning and Bioinformatics Approach for Identifying Key Biomarkers in Gallbladder Cancer Diagnosis and Progression. IET Syst Biol Khatun R, Tasnim W, Akter M, Islam MM, Uddin MA, Das SC, Mahmud MZ. PMID: 40527859 [PubMed - indexed for MEDLINE]
	Methylation aberrations and genomic instability synergistically drive the evolution of intrahepatic cholangiocarcinoma. Epigenomics Li G, Bai Y, Tao F, Hu T, Wang T, Zeng Y, Sun D. PMID: 40527503 [PubMed - indexed for MEDLINE]
	A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index. Liver Int Persano M, Rimini M, Salani F, Prinzi FL, Nichetti F, Saborowski A, Antonuzzo L, Passeri L, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Corallo S, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Fornaro L, De Rosa A, Lanzetta I, Balsano R, Lavacchi D, Camera S, Ikeda M, Dekervel J, Niger M, Tesini G, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Ferrara M, Himmelsbach V, Landriscina M, Djaballah SA, Masi G, Vogel A, Lonardi S, Rimassa L, Casadei-Gardini A. PMID: 40525496 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 16241

Seite 1 von 813



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung